|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS PROVIDED (USED) BY OPERATING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| Net income (loss) | |||||
| Loss (income) from discontinued operations, net of income taxes | |||||
| Adjustments to reconcile income (loss) from continuing operations to cash flows from operating activities | |||||
| Depreciation and amortization | |||||
| Original issue discount and debt issuance cost amortization | |||||
| Deferred income taxes | |||||
| Distributions from equity affiliates | |||||
| Gain from sales of property and equipment | |||||
| Stock based compensation expense - Note O | |||||
| Loss on early retirement of debt | |||||
| Benefit (loss) from excess tax deduction on stock based compensation | |||||
| Income from restricted investments | |||||
| Loss (income) on acquisitions and divestitures, net - Notes B | |||||
| Goodwill impairment | |||||
| Asset impairments | |||||
| Pension contributions | |||||
| Loss (gain) on pension and other postretirement plan remeasurements | |||||
| Change in operating assets and liabilities | |||||
| SUPPLEMENTAL DISCLOSURES | |||||
| Interest paid | |||||
| Income taxes paid (including discontinued operations) | |||||
| Total cash flows provided by operating activities from continuing operations | |||||
| CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Purchase of operations - net of cash acquired | |||||
| Proceeds from sale or restructuring of operations | |||||
| Proceeds from settlement of company-owned life insurance contracts | |||||
| Company-owned life insurance payments | |||||
| Funds restricted for specific transactions | |||||
| Reimbursement from restricted investments | |||||
| Proceeds from sale of securities | |||||
| Purchase of securities | |||||
| Other investing cash flows | |||||
| Proceeds from the settlement of derivative instruments | |||||
| Total cash flows used by investing activities from continuing operations | |||||
| CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of long-term debt | |||||
| Premium on long-term debt repayment | |||||
| Proceeds from (repayment of) short-term debt | |||||
| Repurchase of common stock | |||||
| Debt issuance costs | |||||
| Cash dividends paid | |||||
| Stock based compensation employee withholding taxes paid in cash | |||||
| Total cash flows used by financing activities from continuing operations | |||||
| CASH USED BY CONTINUING OPERATIONS | |||||
| Cash used by discontinued operations | |||||
| Operating cash flows | |||||
| Investing cash flows | |||||
| Total cash used by discontinued operations | |||||
| Effect of currency exchange rate changes on cash and cash equivalents | |||||
| DECREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS - END OF YEAR | |||||
| CHANGES IN ASSETS AND LIABILITIES | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Trade and other payables | |||||
| Other assets and liabilities |
Loading...